Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026)
Sintx Technologies (SINT) posted Change in Accured Expenses of $659000.0 for Q1 2026, up 247.43% on a QoQ basis from -$447000.0 in Q4 2025, and up 14.41% year-over-year from $576000.0 in Q1 2025.
Analysis
Sintx Technologies (SINT) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Change in Accured Expenses for 14 years, with the latest figure at $659000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 14.41% year-over-year to $659000.0 in Q1 2026; TTM through Mar 2026 was -$117000.0, a 62.01% increase from a year earlier, with the FY2025 full-year figure at -$200000.0, up 73.54% from the prior year.
- Change in Accured Expenses was $659000.0 for Q1 2026 at Sintx Technologies, up from -$447000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $659000.0 in Q1 2026, with the low at -$636000.0 in Q3 2024.
- Average Change in Accured Expenses over 5 years is -$27562.5, with a median of -$16500.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 4792.31% in 2024, then soared 350.0% in 2025.
- Over 5 years, Change in Accured Expenses stood at $258000.0 in 2022, then slumped by 105.04% to -$13000.0 in 2023, then soared by 346.15% to $32000.0 in 2024, then slumped by 1496.88% to -$447000.0 in 2025, then soared by 247.43% to $659000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $659000.0 (Q1 2026), -$447000.0 (Q4 2025), and -$537000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Sep 30, 2025 | -537,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | -636,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -20,000.00 |
| Mar 31, 2023 | -337,000.00 |
| Dec 31, 2022 | 258,000.00 |
| Sep 30, 2022 | -116,000.00 |
| Jun 30, 2022 | 138,000.00 |
| Mar 31, 2022 | -54,000.00 |
| Dec 31, 2021 | -153,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | -62,000.00 |
| Mar 31, 2021 | 380,000.00 |